Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study.
Asokan MS, Joan RF, Babji S, Dayma G, Nadukkandy P, Subrahmanyam V, Pandey A, Malagi G, Arya P, Mahajan V, Bhavikatti J, Pawar K, Thorat A, Shah P, Goud RB, Roy B, Rajukutty S, Immanuel S, Agarwal D, Saha S, Shivaraj A, Panikulam P, Shome R, Gulzar SE, Sharma AU, Naik A, Talashi S, Belekar M, Yadav R, Khude P, V M, Shivalingaiah S, Deshmukh U, Bhise C, Joshi M, Inbaraj LR, Chandrasingh S, Ghose A, Jamora C, Karumbati AS, Sundaramurthy V, Johnson A, Ramesh N, Chetan N, Parthiban C, Ahmed A, Rakshit S, Adiga V, D'souza G, Rale V, George CE, John J, Kawade A, Chaturvedi A, Raghunathan A, Dias M, Bhosale A, Raghu P, Shashidhara LS, Vyakarnam A, Bal V, Kang G, Mayor S. Asokan MS, et al. Among authors: babji s. Lancet Reg Health Southeast Asia. 2024 Feb 27;22:100361. doi: 10.1016/j.lansea.2024.100361. eCollection 2024 Mar. Lancet Reg Health Southeast Asia. 2024. PMID: 38482152 Free PMC article.
Phase III randomized clinical studies to evaluate the immunogenicity, lot-to-lot consistency, and safety of ROTAVAC® liquid formulations (ROTAVAC 5C & 5D) and non-inferiority comparisons with licensed ROTAVAC® (frozen formulation) in healthy infants.
P KK, Chiteti SR, Aileni VK, Babji S (late), Blackwelder WC, Kumar A, Vagha J, Nayak U, Mitra M, D N, Kar S, Yadav S, Naidu S, Mahantshetti N, Khalatkar V, Mohapatra S, Purthi PK, Sharma P, Kannan A, Dhongade RK, Prasad SD, Ella R, Vadrevu KM. P KK, et al. Among authors: babji s late. Hum Vaccin Immunother. 2023 Dec 15;19(3):2278346. doi: 10.1080/21645515.2023.2278346. Epub 2023 Nov 15. Hum Vaccin Immunother. 2023. PMID: 37968237 Free PMC article. Clinical Trial.
Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN® induced immunity in COVID-19 exposed Indians.
Rakshit S, Babji S, Parthiban C, Madhavan R, Adiga V, J SE, Chetan Kumar N, Ahmed A, Shivalingaiah S, Shashikumar N, V M, Johnson AR, Ramesh N, B RG, Asokan M, Mayor S, Kang G, D'souza G, Dias M, Vyakarnam A. Rakshit S, et al. Among authors: babji s. NPJ Vaccines. 2023 Sep 14;8(1):134. doi: 10.1038/s41541-023-00731-w. NPJ Vaccines. 2023. PMID: 37709772 Free PMC article.
Characterization of immune responses to two and three doses of the adenoviral vectored vaccine ChAdOx1 nCov-19 and the whole virion inactivated vaccine BBV152 in a mix-and-match study in India.
Chaudhary A, Madhavan R, Babji S, Raju R, Syed C, Kumar A, Saravanan P, Sharon Nikitha O, Leander Xavier JV, David Chelladurai JS, Deborah AA, George A, Kang G, Rose W. Chaudhary A, et al. Among authors: babji s. Vaccine. 2023 Jul 25;41(33):4808-4822. doi: 10.1016/j.vaccine.2023.06.059. Epub 2023 Jun 23. Vaccine. 2023. PMID: 37357073 Free PMC article. Clinical Trial.
Immunogenicity and safety of homologous and heterologous booster vaccination of ChAdOx1 nCoV-19 (COVISHIELD™) and BBV152 (COVAXIN®): a non-inferiority phase 4, participant and observer-blinded, randomised study.
Rose W, Raju R, Babji S, George A, Madhavan R, Leander Xavier JV, David Chelladurai JS, Nikitha OS, Deborah AA, Vijayakumar S, Immanuel S, John J, Rupali P, Abhilash KPP, Mohan VR, Tallapaka KB, Samuel P, Kang G. Rose W, et al. Among authors: babji s. Lancet Reg Health Southeast Asia. 2023 Jan 24;12:100141. doi: 10.1016/j.lansea.2023.100141. Online ahead of print. Lancet Reg Health Southeast Asia. 2023. PMID: 36712811 Free PMC article.
Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults.
Rakshit S, Adiga V, Ahmed A, Parthiban C, Chetan Kumar N, Dwarkanath P, Shivalingaiah S, Rao S, D'Souza G, Dias M, Maguire TJA, Doores KJ, Zoodsma M, Geckin B, Dasgupta P, Babji S, van Meijgaarden KE, Joosten SA, Ottenhoff THM, Li Y, Netea MG, Stuart KD, De Rosa SC, McElrath MJ, Vyakarnam A. Rakshit S, et al. Among authors: babji s. Front Immunol. 2022 Oct 4;13:985938. doi: 10.3389/fimmu.2022.985938. eCollection 2022. Front Immunol. 2022. PMID: 36268023 Free PMC article.
Safety and immunogenicity of the Rotavac and Rotasiil rotavirus vaccines administered in an interchangeable dosing schedule among healthy Indian infants: a multicentre, open-label, randomised, controlled, phase 4, non-inferiority trial.
Kanungo S, Chatterjee P, Bavdekar A, Murhekar M, Babji S, Garg R, Samanta S, Nandy RK, Kawade A, Boopathi K, Kanagasabai K, Kamal VK, Kumar VS, Gupta N, Dutta S. Kanungo S, et al. Among authors: babji s. Lancet Infect Dis. 2022 Aug;22(8):1191-1199. doi: 10.1016/S1473-3099(22)00161-X. Epub 2022 May 16. Lancet Infect Dis. 2022. PMID: 35588754 Free PMC article. Clinical Trial.
BCG revaccination qualitatively and quantitatively enhances SARS-CoV-2 spike-specific neutralizing antibody and T cell responses induced by the COVISHIELD™ vaccine in SARS-CoV-2 seronegative young Indian adults.
Rakshit S, Adiga V, Ahmed A, Parthiban C, Kumar NC, Dwarkanath P, Shivalingaiah S, Rao S, D'Souza G, Dias M, Maguire TJA, Doores K, Dasgupta P, Babji S, Ottenhoff THM, Stuart KD, De Rosa S, McElrath MJ, Vyakarnam A. Rakshit S, et al. Among authors: babji s. Res Sq [Preprint]. 2022 Mar 2:rs.3.rs-1395683. doi: 10.21203/rs.3.rs-1395683/v1. Res Sq. 2022. PMID: 35262071 Free PMC article. Preprint.
91 results